Clinical Trial Update: Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pre-surgery chemotherapy with filgrastim in patients with HER2-positive breast cancer that could be surgically removed; results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor Negative Breast Cancer
• Estrogen Receptor-positive Breast Cancer
• Progesterone Receptor-negative Breast Cancer
• Progesterone Receptor-positive Breast Cancer

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: University of Washington | Conditions: Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-03-12